SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,671,877 | -60.4% | 14,599 | -52.3% | 0.06% | -64.2% |
| Q1 2023 | $4,217,185 | +687.6% | 30,597 | +640.5% | 0.18% | +450.0% |
| Q4 2022 | $535,425 | +8.4% | 4,132 | -37.3% | 0.03% | +77.8% |
| Q2 2022 | $494,000 | -35.2% | 6,590 | -32.4% | 0.02% | -40.0% |
| Q1 2022 | $762,000 | -55.6% | 9,752 | -55.8% | 0.03% | -72.7% |
| Q2 2021 | $1,716,000 | +85.7% | 22,075 | +78.0% | 0.11% | +139.1% |
| Q1 2021 | $924,000 | -18.1% | 12,400 | +54.4% | 0.05% | -13.2% |
| Q3 2020 | $1,128,000 | +1.7% | 8,030 | +16.1% | 0.05% | -5.4% |
| Q2 2020 | $1,109,000 | +203.8% | 6,919 | +85.3% | 0.06% | +115.4% |
| Q1 2020 | $365,000 | – | 3,734 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |